GCDFP-15 positive and TTF-1 negative primary lung neoplasms: A tissue microarray study of 381 primary lung tumors

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 6, 2009, Pages 505-511

  Wang, Li J ^a   Greaves, Wesley Olando ^a   Sabo, Edmond ^a   Noble, Lelia ^a   Tavares, Rosemarie ^a   Ng, Thomas ^a   DeLellis, Ronald A ^a   Resnick, Murray B ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Adenocarcinoma; Gross cystic disease fluid protein 15; Immunohistochemistry; Lung tumors; Small biopsies; Thyroid transcription factor 1

Indexed keywords

GLYCOPROTEIN; GROSS CYSTIC DISEASE FLUID PROTEIN 15; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CARCINOID; CLINICAL FEATURE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARRIER PROTEINS; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROTEIN ARRAY ANALYSIS; RESPIRATORY MUCOSA; TUMOR MARKERS, BIOLOGICAL;

EID: 74249092793     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181a8e809     Document Type: Article

References (37)

1. Mazoujian G, Pinkus GS, Davis S, et al. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol. 1983;110:105-112.
2. Satoh F, Umemura S, Osamura RY. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue. Breast Cancer. 2000;7:49-55.
3. Mazoujian G, Bodian C, Haagensen DE Jr, et al. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors. Cancer. 1989;63:2156-2161.
4. Wick MR, Lillemoe TJ, Copland GT, et al. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alphalactalbumin. Hum Pathol. 1989;20:281-287.
5. Kimura S, Hara Y, Pineau T, et al. The T/ebp null mouse: thyroidspecific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev. 1996;10:60-69.
6. Lazzaro D, Price M, de Felice M, et al. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the fetal brain. Development. 1991;113:1093-1104.
7. Ikeda K, Clark JC, Shaw-White JR, et al. Gene structure and expression of human thyroid transcription factor-1 in respiratory epithelial cells. J Biol Chem. 1995;270:8108-8114.
8. Kelly SE, Bachurski CJ, Burhans MS, et al. Transcription of the lung-specific surfactant protein C gene is mediated by thyroid transcription factor 1. J Biol Chem. 1996;271:6881-6888.
9. Li F, Rosenberg E, Smith CI, et al. Correlation of expression of transcription factor C/EBP alpha and surfactant protein genes in lung cells. Am J Physiol. 1995;269:L241-L247.
10. Mendelson CR. Role of transcription factors in fetal lung development and surfactant protein gene expression. Annu Rev Physiol. 2000;62:875-915.
11. Venkatesh VC, Planer BC, Schwartz M, et al. Characterization of the promoter of human pulmonary surfactant protein B gene. Am J Physiol. 1995;268:L674-L682.
12. Burke LM, Rush WI, Khoor A, et al. Alveolar adenoma: a histochemical, immunohistochemical, and ultrastructural analysis of 17 cases. Hum Pathol. 1999;30:158-167.
13. Chan AC, Chan JK. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1): a new clue to its histogenesis. Am J Surg Pathol. 2000;24:1531-1536.
14. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, et al. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol. 2000;24:906-916.
15. Yatabe Y, Mitsudomi T, Takahashi T. TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol. 2002;26:767-773.
16. Maeshima AM, Omatsu M, Tsuta K, et al. Immunohistochemical expression of TTF-1 in various cytological subtypes of primary lung adenocarcinoma, with special reference to intratumoral heterogeneity. Pathol Int. 2008;58:31-37.
17. Penman D, Downie I, Roberts F. Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution. J Clin Pathol. 2006;59:663-664.
18. Graham AD, Williams AR, Salter DM. TTF-1 expression in primary ovarian epithelial neoplasia. Histopathology. 2006;48: 764-765.
19. Siami K, McCluggage WG, Ordonez NG, et al. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas. Am J Surg Pathol. 2007;31:1759-1763.
20. Zhang PJ, Gao HG, Pasha TL, et al. TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems. Int J Gynecol Pathol. 2009;28:10-18.
21. Kubba LA, McCluggage WG, Liu J, et al. Thyroid transcription factor-1 expression in ovarian epithelial neoplasms. Mod Pathol. 2008;21:485-490.
22. Di Loreto C, Di Lauro V, Puglisi F, et al. Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma. J Clin Pathol. 1997;50:30-32.
23. Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology. 2000;36:8-16.
24. Puglisi F, Barbone F, Damante G, et al. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. Mod Pathol. 1999;12:318-324.
25. Pelosi G, Fraggetta F, Pasini F, et al. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol. 2001;25:363-372.
26. Moldvay J, Jackel M, Bogos K, et al. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res. 2004;10:85-88.
27. Bejarano PA, Baughman RP, Biddinger PW, et al. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol. 1996;9:445-452.
28. Travis WD, Brambilla E, Muller-Hermelink HK, et al. World Health Organization Classification of Tumours, Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: World Health Organization; 2004.
29. Colby TV, Koss MN, Travis WD. Atlas of Tumour Pathology, Series 4. Tumors of the Lower Respiratory Tract. Washington, DC: Armed Forces Institute of Pathology; 1996.
30. Gazdar AF, Carney DN, Minna JD. The biology of non-small cell lung cancer. Semin Oncol. 1983;10:3-19.
31. Tavassoli FA, Devilee P. World Health Organization Classification of Tumours, Pathology and Genetics. Tumours of the Breast and Female Genital Organs. Lyon, France: World Health Organization; 2003.
32. Cagle PT, Mody DR, Schwartz MR. Estrogen and progesterone receptors in bronchogenic carcinoma. Cancer Res. 1990;50:6632-6635.
33. Dabbs DJ, Landreneau RJ, Raab SS, et al. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg. 2002;73:403-405.
34. Dabbs DJ. Diagnostic Immunohistochemistry. Philadelphia, PA: Churchill Livingstone; 2006.
35. Su JM, Hsu HK, Chang H, et al. Expression of estrogen and progesterone receptors in non-small cell lung cancer: immunohistochemical study. Anticancer Res. 1996;16:3803-3806.
36. Takeda Y, Tsuta K, Shibuki Y, et al. Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Arch Pathol Lab Med. 2008;132:239-243.
37. Striebel JM, Dacic S, Yousem SA. Gross cystic disease fluid protein- (GCDFP-15): expression in primary lung adenocarcinoma. Am J Surg Pathol. 2008;32:426-432.